Hasegawa-Minato J - Search Results

1

A Retrospective Analysis of Clinical Biomarkers for Olaparib Maintenance Therapy in Patients with Recurrent Ovarian Cancer.

Endo S, Shigeta S, Tokunaga H, Shimizu T, Hasegawa-Minato J, Hashimoto C, Ishibashi M, Nagai T, Shiga N, Shimada M, Yaegashi N. Endo S, et al. Among authors: hasegawa minato j. Tohoku J Exp Med. 2022 Aug 5;258(1):1-9. doi: 10.1620/tjem.2022.J050. Epub 2022 Jun 16. Tohoku J Exp Med. 2022. PMID: 35705321 Free article.

2

Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers.

Hasegawa-Minato J, Toyoshima M, Ishibashi M, Zhang X, Shigeta S, Grandori C, Kitatani K, Yaegashi N. Hasegawa-Minato J, et al. Oncotarget. 2017 Dec 15;9(3):3483-3496. doi: 10.18632/oncotarget.23322. eCollection 2018 Jan 9. Oncotarget. 2017. PMID: 29423060 Free PMC article.

3

Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancer.

Ishibashi M, Toyoshima M, Zhang X, Hasegawa-Minato J, Shigeta S, Usui T, Kemp CJ, Grandori C, Kitatani K, Yaegashi N. Ishibashi M, et al. Among authors: hasegawa minato j. Sci Rep. 2018 Sep 4;8(1):13207. doi: 10.1038/s41598-018-31069-2. Sci Rep. 2018. PMID: 30181600 Free PMC article.

4

Involvement of small extracellular vesicle-derived TIE-1 in the chemoresistance of ovarian cancer cells.

Misawa T, Toyoshima M, Kitatani K, Ishibashi M, Hasegawa-Minato J, Shigeta S, Yaegashi N. Misawa T, et al. Among authors: hasegawa minato j. Cancer Treat Res Commun. 2021;27:100364. doi: 10.1016/j.ctarc.2021.100364. Epub 2021 Mar 28. Cancer Treat Res Commun. 2021. PMID: 33812182 Free article.

5

Assessing the Significance of Lymphadenectomy in Older Patients with Stage I Endometrial Cancer: A Single-Center, Retrospective Cohort Study.

Hasegawa-Minato J, Shigeta S, Shimada M, Ishibashi M, Hashimoto C, Shibuya Y, Nagai T, Tokunaga H, Niikura H, Yaegashi N. Hasegawa-Minato J, et al. Tohoku J Exp Med. 2023 Sep 26;261(1):83-93. doi: 10.1620/tjem.2023.J055. Epub 2023 Jul 6. Tohoku J Exp Med. 2023. PMID: 37407439 Free article.

6

Lenvatinib plus Pembrolizumab Combination Therapy for Advanced or Recurrent Endometrial Cancer: A Single-Center, Retrospective Analysis.

Tochigi M, Shigeta S, Shimada M, Miyahara S, Hasegawa-Minato J, Shibuya Y, Ishibashi M, Hashimoto C, Tokunaga H, Yaegashi N. Tochigi M, et al. Among authors: hasegawa minato j. Tohoku J Exp Med. 2024 Feb 27;262(2):85-95. doi: 10.1620/tjem.2023.J095. Epub 2023 Nov 23. Tohoku J Exp Med. 2024. PMID: 38008437 Free article.

7

Reports of the 2019 ACOG Annual Clinical and Scientific Meeting in Nashville, Tennessee.

Haraguchi H, Imamura Y, Kokabu T, Hasegawa-Minato J, Kobayashi M, Nagayasu Y, Sekine M, Yanaihara N. Haraguchi H, et al. Among authors: hasegawa minato j. J Obstet Gynaecol Res. 2020 Jan;46(1):5-8. doi: 10.1111/jog.14127. Epub 2019 Oct 16. J Obstet Gynaecol Res. 2020. PMID: 31621160 No abstract available.

8

ExcLAMation marks in a pelvic lymph node.

Muroyama Y, Inoue C, Fujishima F, Shigeta S, Hasegawa-Minato J, Shimada M, Suzuki T. Muroyama Y, et al. Among authors: hasegawa minato j. Clin Case Rep. 2023 Dec 14;11(12):e8339. doi: 10.1002/ccr3.8339. eCollection 2023 Dec. Clin Case Rep. 2023. PMID: 38098800 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page